Company Name: Selecta Biosciences, Inc.
Selecta Biosciences, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of targeted therapies designed to modulate the immune system using its proprietary synthetic vaccine particle (SVP) technology.
Ticker Symbol: SELB (NASDAQ)
Company Website: http://selectabio.com
Social Media: Selecta Biosciences LinkedIn
Headquarters: Watertown, MA